Abstract
Donepezil (Don) is one of the main compounds used in the therapy of Alzheimer’s disease. In this study, donepezil hydrochloride was investigated for solid-state compatibility with several pharmaceutical excipients like calcium lactate (CaL), mannitol (Man), magnesium stearate (MgSt), anhydrous lactose (LAnh), talc (T), magnesium citrate (MgC), sorbitol (Sb), silica (SiO2), polyvinylpyrrolidone K30 (PVP), sodium carboxymethylcellulose (NaCMC) and starch (St) under ambient conditions, by ATR–FTIR spectroscopy and PXRD data, and later by thermoanalytical techniques (TG/DTG/HF), in order to evaluate the thermal-induced interactions. The instrumental investigations carried at ambiental temperature revealed no interaction between Don and selected excipients, while thermal treatment induced interactions between components in eight binary mixtures, except the ones containing magnesium citrate, talc and polyvinylpyrrolidone.
Similar content being viewed by others
References
Kudo T, Davis KL, Blesa Gonzalez R, Wilkinson DG. Practical pharmacology for Alzheimer’s disease. 1st ed. Berlin: Springer; 2016.
Meyer MA. Neurologic disease: a modern pathophysiologic approach to diagnosis and treatment. 1st ed. Berlin: Springer; 2016.
https://www.drugbank.ca/drugs/DB00843. Accessed 10 December 2016.
Akasofu S, Kimura M, Kosasa T, Sawada K, Ogura H. Study of neuroprotection of donepezil, a therapy for Alzheimer’s disease. Chem Biol Interact. 2008;175(1–3):222–6.
Cutuli D, De Bartolo P, Caporali P, Tartaglione AM, Oddi D, D’Amato FR, Nobili A, D’Amelio M, Petrosini L. Neuroprotective effects of donepezil against cholinergic depletion. Alzheimers Res Ther. 2013;5(5):50.
Winblad B, Engedal K, Soininen H, Verhey F, Waldemar G, Wimo A, Wetterholm AL, Zhang R, Haglund A, Subbiah P. A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD. Neurology. 2001;57(3):489–95.
Courtney C, Farrell D, Gray R, Hills R, Lynch L, Sellwood E, Edwards S, Hardyman W, Raftery J, Crome P, Lendon C, Shaw H, Bentham P. Long-term donepezil treatment in 565 patients with Alzheimer’s disease (AD2000): randomised double-blind trial. Lancet. 2004;363(9427):2105–15.
Burns A, Gauthier S, Perdomo C. Efficacy and safety of donepezil over 3 years: an open-label, multicentre study in patients with Alzheimer’s disease. Int J Geriatr Psychiatry. 2007;22(8):806–12.
Inglis F. The tolerability and safety of cholinesterase inhibitors in the treatment of dementia. Int J Clin Pract Suppl. 2002;127:45–63.
Mauskopf JA, Paramore C, Lee WC, Snyder EH. Drug persistency patterns for patients treated with rivastigmine or donepezil in usual care settings. J Manag Care Pharm. 2005;11(3):231–51.
Small G, Dubois B. A review of compliance to treatment in Alzheimer’s disease: potential benefits of a transdermal patch. Curr Med Res Opin. 2007;23(11):2705–13.
Saluja S, Kasha PC, Paturi J, Anderson C, Morris R, Banga AK. A novel electronic skin patch for delivery and pharmacokinetic evaluation of donepezil following transdermal iontophoresis. Int J Pharm. 2013;453(2):395–9.
Guo W, Quan P, Fang L, Cun D, Yang M. Sustained release donepezil loaded PLGA microspheres for injection: preparation, in vitro and in vivo study. Asian J Pharm Sci. 2015;10(5):405–14.
Liew KB, Tan YTF, Peh KK. Characterization of oral disintegrating film containing donepezil for Alzheimer disease. AAPS PharmSciTech. 2012;13(1):134–42.
Kearney MC, Caffarel-Salvador E, Fallows SJ, McCarthy HO, Donnelly RF. Microneedle-mediated delivery of donepezil: potential for improved treatment options in Alzheimer’s disease. Eur J Pharm Biopharm. 2016;103:43–50.
Kim JY, Han MR, Kim YH, Shin SW, Nam SY, Park JH. Tip-loaded dissolving microneedles for transdermal delivery of donepezil hydrochloride for treatment of Alzheimer’s disease. Eur J Pharm Biopharm. 2016;105:148–55.
Chaudhari SP, Patil PS. Pharmaceutical excipients: a review. Int J Adv Pharm Biol Chem. 2012;1(1):21–34.
Elder DP, Kuentz M, Holm R. Pharmaceutical excipients—quality, regulatory and biopharmaceutical considerations. Eur J Pharm Sci. 2016;87:88–99.
Maswadeh HM. Incompatibility study of ibuprofen in ternary interactive mixture by using differential scanning calorimetry. J Therm Anal Calorim. 2015. doi:10.1007/s10973-015-4773-z.
Gao R, Jin Y, Yang QY, Sun BW, Lin J. Study of stability and drug-excipient compatibility of estradiol and pharmaceutical excipients. J Therm Anal Calorim. 2015;120(1):839–45.
Fuliaş A, Vlase G, Vlase T, Şuta L-M, Şoica C, Ledeţi I. Screening and characterization of cocrystal formation between carbamazepine and succinic acid. J Therm Anal Calorim. 2015;121(3):1081–6.
Ledeţi I, Vlase G, Ciucanu I, Olariu T, Fuliaş A, Şuta L-M, Belu I. Analysis of solid binary systems containing simvastatin. Rev Chim. 2015;66(2):240–3.
Fuliaş A, Soica C, Ledeţi I, Vlase T, Vlase G, Şuta L-M, Belu A. Characterization of pharmaceutical acetylsalicylic acid—theophylline cocrystal obtained by slurry method under microwave irradiation. Rev Chim. 2014;65(11):1281–4.
Fuliaş A, Vlase G, Ledeţi I, Şuta L-M. Ketoprofen-cysteine equimolar salt: synthesis, thermal analysis, PXRD and FTIR spectroscopy investigation. J Therm Anal Calorim. 2015;121(3):1087–91.
Park TJ, Ko DH, Kim YJ, Kim YG. Polymorphic characterization of pharmaceutical solids, donepezil hydrochloride, by C CP/MAS solid-state nuclear magnetic resonance spectroscopy. B Kor Chem Soc. 2009;30(9):2007–10.
Gombas A, Szabo-Revesz P, Regdon G Jr, Eros I. Study of thermal behaviour of sugar alcohols. J Therm Anal Calorim. 2003;73(2):615–21.
Acknowledgements
This work was supported by the PN-II-RU-TE-2014-4-0515 to Ionuţ Ledeţi, Gabriela Vlase, Lenuţa-Maria Şuta and Adriana Ledeţi.
Author information
Authors and Affiliations
Corresponding author
Additional information
Ionut Ledeti and Sorin Bolintineanu contributed equally to this work.
Rights and permissions
About this article
Cite this article
Ledeti, I., Bolintineanu, S., Vlase, G. et al. Evaluation of solid-state thermal stability of donepezil in binary mixtures with excipients using instrumental techniques. J Therm Anal Calorim 130, 425–431 (2017). https://doi.org/10.1007/s10973-017-6250-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10973-017-6250-3